Susquehanna International Group’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-127,313
| Closed | -$25K | – | 5288 |
|
|
2019
Q1 | $25K | Buy |
127,313
+94,268
| +285% | +$18.5K | ﹤0.01% | 2827 |
|
|
2018
Q4 | $23K | Buy |
33,045
+21,806
| +194% | +$15.2K | ﹤0.01% | 3440 |
|
|
2018
Q3 | $14K | Buy |
+11,239
| New | +$14K | ﹤0.01% | 3205 |
|
|
2018
Q2 | – | Sell |
-31,338
| Closed | -$63K | – | 5197 |
|
|
2018
Q1 | $63K | Buy |
31,338
+17,824
| +132% | +$35.8K | ﹤0.01% | 3083 |
|
|
2017
Q4 | $16K | Sell |
13,514
-17,329
| -56% | -$20.5K | ﹤0.01% | 3552 |
|
|
2017
Q3 | $39K | Sell |
30,843
-32,400
| -51% | -$41K | ﹤0.01% | 2984 |
|
|
2017
Q2 | $84K | Buy |
63,243
+27,331
| +76% | +$36.3K | ﹤0.01% | 3284 |
|
|
2017
Q1 | $67K | Sell |
35,912
-32,924
| -48% | -$61.4K | ﹤0.01% | 3026 |
|
|
2016
Q4 | $357K | Buy |
+68,836
| New | +$357K | ﹤0.01% | 3269 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4656 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4791 |
|
|
2015
Q3 | – | Sell |
-15,424
| Closed | -$95K | – | 4732 |
|
|
2015
Q2 | $95K | Sell |
15,424
-35,792
| -70% | -$220K | ﹤0.01% | 4260 |
|
|
2015
Q1 | $412K | Buy |
51,216
+38,082
| +290% | +$306K | ﹤0.01% | 3253 |
|
|
2014
Q4 | $66K | Buy |
+13,134
| New | +$66K | ﹤0.01% | 4239 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 4451 |
|
|
2014
Q2 | – | Sell |
-21,075
| Closed | -$148K | – | 4568 |
|
|
2014
Q1 | $148K | Buy |
+21,075
| New | +$148K | ﹤0.01% | 3316 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 4312 |
|